In Brief: Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Medtronic: Hopes to make a premarket submission to FDA during the fourth quarter for the Micro Jewel Model 7221 automatic implantable cardioverter defibrillator, Chief Financial Officer Robert Ryan tells investors Sept. 13 at the Dain Bosworth Healthcare Conference in Minneapolis. The Micro Jewel, a 69 cc device with 15 minutes of event recording, is 14 cc smaller than the current Jewel and Jewel Plus Models, and is roughly the same size as Guidant's Ventak Mini AICD, for which a PMA supplement was filed in June. Ryan adds that Medtronic is developing the Micro Model 7223, which "will be the same size as the 7221, and offer rate-responsive brady pacing and incorporate advanced detection algorithms"...